The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

March 2021 Quarterly Report

30 Apr 2021 11:17

RNS Number : 2474X
Aura Energy Limited
30 April 2021
 

 

30 April 2021

AURA ENERGY LIMITED

("Aura" or the "Company")

March 2021 Quarterly Report

TO VIEW THE FULL PDF VERSION OF THIS REPORT CLICK HERE:

 http://www.rns-pdf.londonstockexchange.com/rns/2474X_1-2021-4-30.pdf

Aura Energy (ASX:AEE) ("Aura Energy", the "Company") is pleased to provide an overview of the Company's activities for the period ending 31 March 2021 ("Quarter", "Reporting Period").

 

Highlights:

· Aura launched a Rights Issue to eligible shareholders for 1 share for every 2 shares held post share consolidation, at a price of $0.026 per share, with strong support from shareholders.

· Three months from the record date, which will announced once confirmed ("Record Date") the Company will also offer 1 Loyalty Option Rights Issue for every 3 Shares held, with the Loyalty Options having an upfront payment of $0.013 each, an exercise price of $0.052, and expiry of 30 June 2024.

· The recent placement coupled with the fully underwritten Rights Issue and Loyalty Options Rights Issue will recapitalise the Company, strongly positioning Aura to expedite the development of the zero emission Tiris Uranium Project.

· The Company held its AGM on 17 March 2021, whereby all 17 resolutions were voted on with 95% acceptance.

· Martin Rogers appointed as Non-Executive Chairman, contributing significant experience as a successful start-up investor and director, with Chemical Engineering and Computer Science degrees, and a depth of experience in incubating companies and listed entities.

· Peter Ward appointed as Non-Executive Director, with 25+ years' professional experience in equities sales, corporate finance, research and stock broking/trading, with a primary focus on the wholesale and institutional markets both in Australia and SE Asia.

· Phillip Hains appointed as Company Secretary, with over 30 years' experience in corporate accounting, administration, general management and having served on a number of public listed Companies, Committees and Boards.

 

Commenting on the Reporting Period, Aura Energy Non-Executive Chairman, Martin Rogers, said:

"During the March Quarter, we have made significant progress in advancing the Company towards resumption of trading on the ASX, as we seek to fast track the development of our zero emission Tiris Uranium Project.

To capitalise on the shift towards decarbonised energy, following received approval for a share capital consolidation, we launched a fully underwritten rights issue for eligible shareholders, which coupled with the recent placement and loyalty options rights issue, will provide significant capital to the Company, strongly positioning Aura Energy for 2021.

The Loyalty Options Rights Issue will take place three months from the Record Date, as a further incentive for shareholders to maintain their position in the Company. I strongly encourage shareholders to maintain their holding in Aura Energy.

I would like to thank all shareholders for their support to date and look forward to an exciting year for the Company."

 

 

Rights Issue and Share Consolidation

Although occurring outside the Reporting Period, on 1 April 2021, Aura Energy announced a Rights Issue to eligible shareholders for 1 share for every 2 shares held post the consolidation, at a price of $0.026 per share. The Rights Issue is the product of a strategy conceived by some of the Company's major shareholders to rebuild Aura Energy as the Company focuses on the fast tracked development of its zero emission Tiris Uranium Project.

Three months from the Record Date, the Company will also offer 1 Loyalty Option Rights Issue for every 3 Shares held, with the Loyalty Options having an upfront payment of $0.013 each, an exercise price of $0.052, and expiry of 30 June 2024.

Both the Rights Issue and Loyalty Option Rights Issue are underwritten by KTM Capital and the share consolidation was undertaken at a 13:1 ratio.

 

Tiris Uranium Project

During the Reporting Period, no activity took place on the Tiris Project, however the recent placement coupled with the fully underwritten Rights Issue and Loyalty Options Rights Issue will provide A$5.8m in capital to the Company, strongly positioning Aura to expedite the development of the zero emission Tiris Uranium Project.

 

AGM Resolutions

On 17 March 2021, the Company held its Annual General Meeting ("AGM), whereby all 17 resolutions were voted on with 95% acceptance. The resolutions which were passed by shareholders have precipitated the finalisation of legal settlements, reconfiguration of the Board of Directors and resolutions to allow the passage of a significant fund raising via a rights issue.

During the Quarter, the Company's project and technical activities were largely on hold as refinancing plans continued following the settlement with shareholder activists.

 

Board and Management Appointments

During the Reporting Period, the Company made several changes to its Board and management appointments, which aligns with Aura Energy's strategy to recapitalise the Company and expedite the development of the zero emission Tiris Uranium Project.

Martin Rogers appointed as Non-Executive Chairman

Martin Rogers was appointed as Non-Executive Chairman, contributing significant experience as a successful start-up investor and director, with Chemical Engineering and Computer Science degrees, and a depth of experience in incubating companies and listed entities.

Mr Rogers holds experience in all aspects of financial, strategic and operational management, and is an investor and senior executive in a private funded advisory business across multiple sectors.

He was instrumental in establishing KTM Ventures, an Early Stage Venture Capital Limited Partnership, providing higher returns in a tax-effective fund focused upon pre-IPO and private expansion capital, and is the former Chairman of Actinogen (ASX:ACW) and Rhinomed (ASX:RNO), Non-Executive Director OncoSil Medical (ASX:OSL) and Cellmid (ASX:CDY), and former CEO for Prima BioMed Ltd (ASX:PRR).

 

Peter Ward appointed as Non-Executive Director

Peter Ward was appointed as Non-Executive Director, with 25+ years' professional experience in equities sales, corporate finance, research and stock broking/trading with a primary focus on the wholesale and institutional markets both in Australia and SE Asia.

Mr Ward has developed considerable industry experience across the small cap markets with particular knowledge of the mining, energy, technology, industrial, and financial services sector, having advised on and completed multiple capital raisings in support of companies' growth initiatives.

He has held senior institutional research sales and corporate advisory role with leading small cap equities houses, Southern Cross Equities, Austock Group and Henslow.

Mr Ward holds a Bachelor of Business (Banking and Finance) from Monash University.

Phillip Hains appointed as Company Secretary

Mr Hains was appointed Company Secretary, with over 30 years' experience in corporate accounting, administration, general management, having served on a number of public listed Companies, Committees and Boards.

He completed his MBA from RMIT and obtained his Public Practice Certificate from the Institute of Chartered Accountants. 

Covid-19 Impact

Covid-19 continues to restrict access to the Company projects (both the Australian government and to a lesser extent Mauritanian government travel bans).

 

Aura lists its assets as:

· The construction-ready Tiris Uranium Project

· Excellent gold assets

· Häggån Vanadium Project

· Swedish compensation claim

· A corporate transaction for the gold assets continues, albeit at a slower pace.

· The Swedish compensation claim is ongoing and focussed on funding arrangements for this litigation

Häggån Battery Metals Project, Sweden (Aura 100%)

Activities at the Häggån Battery Metals project remained on care-and-maintenance.

 

The Swedish compensation claim remains ongoing and Aura continues to be steadfast in action to recover the value of the confiscated asset.

 

Tasiast South Gold Project, Mauritania (Aura 100%)

A corporate transaction for the gold assets continues, albeit at a slower pace.

 

Share Issue

The Company completed a share issue to pay outstanding Director remuneration and settlement of legal cost.

 

Financial Operations

The closing cash at the end of the Quarter was A$710k, compared to A$52k at the end of the previous December 2020. This is mainly due to the placement of A$800k approved by the shareholders in the Annual General Meeting.

 

The Company did not pay any amounts during the Quarter to any of its related parties (as shown in section 6 of the Appendix 5B). 

 

The Company is in the process of obtaining regulatory approval for the resumption of trading of the Company on the ASX.

For Further Information, please contact:

Martin Rogers

Aura Energy Limited

Non-Executive Chairman

martin@ktmcapital.com.au

+61 428 268 357

Jane Morgan

JMM

Investor & Media Relations

jm@janemorganmanagement.com.au

+61 405 555 618

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

Ewan Leggat

Caroline Rowe

Telephone: +44 (0) 203 470 0470

 

WH Ireland Limited

(Joint Broker)

Adrian Hadden

James Sinclair-Ford

Telephone: +44 (0) 207 220 1666

 

 

 The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDWPUBUCUPGGUU
Date   Source Headline
29th Nov 20238:50 amRNSResult of AGM
29th Nov 20237:00 amRNSNew Tiris Project Tenements Applications
21st Nov 20237:27 amRNSIssue of Equity
16th Nov 20238:20 amRNSIssue of Equity
10th Nov 20237:25 amRNSIssue of Equity
10th Nov 20237:21 amRNSNew Corporate Presentation
3rd Nov 20238:10 amRNSTotal Voting Rights
1st Nov 20237:55 amRNSNew Corporate Presentation
31st Oct 20237:51 amRNSAnnual Report & Notice of Annual General Meeting
30th Oct 20237:49 amRNSQuarterly Report for Period Ending 30 September 23
30th Oct 20237:41 amRNSIssue of Equity
17th Oct 20237:00 amRNSNew Uranium Exploration Target
13th Oct 20238:35 amRNSIssue of Equity
11th Oct 20238:05 amRNSIssue of Equity
4th Oct 20238:26 amRNSTotal Voting Rights
28th Sep 202310:46 amRNSIssue of Equity
26th Sep 202312:26 pmRNSFinancial Report for the year ended 30 June 23
26th Sep 20238:38 amRNSIssue of Equity
21st Sep 20237:24 amRNSIssue of Equity
14th Sep 20237:10 amRNSHolding(s) in Company
12th Sep 20237:00 amRNSChange of Company Secretary
5th Sep 20238:07 amRNSHäggån Scoping Study
31st Aug 20237:00 amRNSChange of share registry address
31st Aug 20237:00 amRNSIssue of Equity
31st Aug 20237:00 amRNSTotal Voting Rights
17th Aug 20237:27 amRNSIssue of Equity
4th Aug 20237:00 amRNSChange of registered office
31st Jul 20237:17 amRNSQuarterly Report for the Period Ending 30 June 23
27th Jul 20237:58 amRNSIssue of Equity
17th Jul 20237:57 amRNSHoldings in Company
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20238:01 amRNSHoldings in Company
20th Jun 20237:00 amRNSSuccessful Share Purchase Plan Completed
9th Jun 20237:00 amRNSShare Purchase Plan offer closing on 13 June 2023
2nd Jun 20237:00 amRNSIssue of Equity
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSIssue of Equity
17th May 20237:00 amRNSCleansing Notice
16th May 20237:00 amRNSHoldings in Company
10th May 20237:07 amRNSCleansing Notice
3rd May 20237:18 amRNSA$10 million Placement to Support its Project
2nd May 20237:00 amRNSASX Trading Halt
28th Apr 20237:45 amRNSQuarterly Report for the Period Ending 31 March 23
4th Apr 20237:10 amRNSExpiry of options
4th Apr 20237:00 amRNSASX Trading Halt Update
3rd Apr 20239:52 amRNSUpdate on uranium mining ban in Sweden
3rd Apr 20238:42 amRNSDirector Dealing
31st Mar 202311:05 amRNSSecond Price Monitoring Extn
31st Mar 202311:00 amRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.